The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 07, 2022
Filed:
Sep. 03, 2018
Applicant:
Ac Bioscience SA, Ecublens, CH;
Inventors:
Christian Auclair, Saint Arnoult en Yvelines, FR;
Esther Fellous, Paris, FR;
Patrice Le Pape, Vertou, FR;
Jorge E. Kalil-Filho, Sao Paulo SP, BR;
Assignee:
Other;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/353 (2006.01); A61P 31/00 (2006.01); A61P 29/00 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 31/045 (2006.01); A61K 31/196 (2006.01);
U.S. Cl.
CPC ...
A61K 31/353 (2013.01); A61K 9/0014 (2013.01); A61K 9/107 (2013.01); A61K 31/045 (2013.01); A61K 31/196 (2013.01); A61P 29/00 (2018.01); A61P 31/00 (2018.01);
Abstract
The present invention relates to a composition comprising a combination of a (halogenoacetamido)benzoate, a flavonol and a terpene, and, as example, relates to a composition comprising the combination of ethyl 3-(2-chloroacetamido)benzoate, dihydroquercetin and bisabolol. Said composition is for use in the treatment of leishmaniasis, especially cutaneous or mucosal leishmaniasis, the composition being applied topically for concomitantly treating both parasitic infection and skin inflammation of the infected area induced by leishmaniasis.